Two Seas Capital’s Esperion Therapeutics ESPR Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$31.2M Sell
11,394,833
-507,688
-4% -$1.61M 1.44% 24
2025
Q4
$44M Buy
11,902,521
+2,152,797
+22% +$6.96M 2.58% 18
2025
Q3
$25.8M Sell
9,749,724
-205,251
-2% -$397K 1.55% 25
2025
Q2
$9.8M Buy
9,954,975
+3,024,104
+44% +$3.03M 0.96% 26
2025
Q1
$9.98M Buy
6,930,871
+700,000
+11% +$1.29M 1.55% 19
2024
Q4
$13.7M Sell
6,230,871
-353,407
-5% -$824K 1.62% 15
2024
Q3
$10.9M Buy
6,584,278
+848,618
+15% +$1.71M 1.84% 12
2024
Q2
$12.7M Buy
5,735,660
+1,570,003
+38% +$3.69M 2.08% 11
2024
Q1
$11.2M Sell
4,165,657
-3,520,463
-46% -$8.55M 2.19% 9
2023
Q4
$23M Buy
7,686,120
+13,950
+0.2% +$18.1K 5.66% 3
2023
Q3
$7.52M Buy
7,672,170
+4,730,298
+161% +$6.84M 1.52% 8
2023
Q2
$4.09M Buy
+2,941,872
New +$4.11M 0.89% 6

Other funds holding ESPR